Osteoprotegerin Reverses Osteoporosis by Inhibiting Endosteal Osteoclasts and Prevents Vascular Calcification by Blocking a Process Resembling Osteoclastogenesis

Journal of Experimental Medicine - United States
doi 10.1084/jem.192.4.463
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Rockefeller University Press

Related search

Osteoprotegerin Expressed by Osteoclasts

Journal of Dental Research
Dentistry
2014English

Phosphonoformic Acid Prevents Vascular Smooth Muscle Cell Calcification by Inhibiting Calcium-Phosphate Deposition

Arteriosclerosis, Thrombosis, and Vascular Biology
Cardiovascular MedicineCardiology
2009English

Estrogen Inhibits Vascular Calcification via Vascular RANKL System: Common Mechanism of Osteoporosis and Vascular Calcification

Circulation Research
Cardiovascular MedicinePhysiologyCardiology
2010English

Hydrogen Peroxide Prevents Vascular Calcification Induced ROS Production by Regulating NRF-2 Pathway

Renal Failure
MedicineNephrologyCritical CareIntensive Care Medicine
2016English

mTORC1 Activation in Osteoclasts Prevents Bone Loss in a Mouse Model of Osteoporosis

Frontiers in Pharmacology
Pharmacology
2019English

Vascular Calcification and Osteoporosis. The Links and Conditions Interference. Review.

Complex Issues of Cardiovascular Diseases
2017English

Osteoprotegerin, Pericytes and Bone-Like Vascular Calcification Are Associated With Carotid Plaque Stability

PLoS ONE
Multidisciplinary
2014English

Resveratrol Prevents Osteoporosis by Upregulating FoxO1 Transcriptional Activity

International Journal of Molecular Medicine
MedicineGenetics
2017English

Puerarin Inhibits the Osteoclastogenesis by Inhibiting RANKL-dependent and –Independent Autophagic Responses

BMC Complementary and Alternative Medicine
MedicineAlternative MedicineComplementary
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy